An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
Read more
Ultra Long Acting Insulin Degludec Reduces Nocturnal Hypoglycemia
Posted in Glucose & Insulin